1. Experimental study on the treatment of the secondary osteoporosis of spinal cord injury with Erxian decoction.
- Author
-
ZHOU Xingmao, WANG Weiqun, SHI Xuguang, ZENG Yuangui, WU Meiyin, and WU Junzhe
- Abstract
Objective To study the therapeutic effect of Erxian decoction on secondary osteoporosis of spinal cord injury (SCI). Methods Modified Allen's method was used to establish the SCI model. Then the rats were divided into SCI model group, SCI Erxian decoction group, and SCI Fosamax group randomly. The treatment with the corresponding drug lasted for 8 weeks. The change of body weight and BBB scales were recorded. Serum ALP and calcium were examined on 4 and 8 weeks of the experiment. The organ coefficients were calculated after the experiment. Results The BBB scales of the established animal model were 0 or 1. Erxian decoction could improve the back limb movement, adjust the hepatic and testicle index of SCI rats, but the effect was weaker than Fosamax. After 4-week of the operation, the serum ALP level decreased but calcium content increased. After 8-week of the operation, the levels of ALP and calcium were close to the normal level. The calcium content significantly reduced after treatment with Erxian decoction. Conclusion Erxian decoction has a therapeutic effect on secondary osteoporosis of SCI. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF